Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Carcinoma and meta-analysis and NAT2[original query] |
|---|
| GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 2011 Feb 32 (2): 182-9. Moore L E, Baris D R, Figueroa J D, Garcia-Closas M, Karagas M R, Schwenn M R, Johnson A T, Lubin J H, Hein D W, Dagnall C L, Colt J S, Kida M, Jones M A, Schned A R, Cherala S S, Chanock S J, Cantor K P, Silverman D T, Rothman |
| Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. Journal of cancer research and clinical oncology 2011 Nov 137 (11): 1661-7. Ying Xin-Jiang, Dong Pin, Shen Bin, Wang Jie, Wang Sang, Wang G |
| Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis. Oncology letters 2012 Feb 3 (2): 429-434. Zheng Youyang, Li Yong, Teng Yaoshu, Zhang Zhen, Cao Xiaol |
| NAT2 polymorphisms with oral carcinoma susceptibility: a meta-analysis. Molecular biology reports 2012 Sep 39 (9): 8813-9. Zhuo Xian-Lu, Ling Jun-Jun, Zhou Yan, Zhao Hou-Yu, Song Yu-Feng, Tan Ying-H |
| Joint effect of polymorphism in the N-acetyltransferase 2 gene and smoking on hepatocellular carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Aug 33 (4): 1059-63. Zhang Jie, Xu Feng, Ouyang Chunh |
| N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies. Gene 2020 Jul 757 144924. Song Yuxuan, Qi Xiangjie, Liu Xiaoqia |
- Page last reviewed:Feb 1, 2024
- Content source: